Search

Your search keyword '"Behrens, Steffen"' showing total 222 results

Search Constraints

Start Over You searched for: Author "Behrens, Steffen" Remove constraint Author: "Behrens, Steffen"
222 results on '"Behrens, Steffen"'

Search Results

1. Detection of Viral Infection and Bacterial Coinfection and Superinfection in Coronavirus Disease 2019 Patients Presenting to the Emergency Department Using the 29-mRNA Host Response Classifier IMX-BVN-3: A Multicenter Study

2. Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

3. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

5. Arrhythmia monitoring and outcome after myocardial infarction (BIO|GUARD-MI): a randomized trial

6. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

7. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

8. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients

10. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

11. Outcomes After Left Main Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock (from the German ALKK PCI Registry)

13. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

14. Infektionsquellensuche bei ambulant erworbenen Fällen von Legionärskrankheit – Ergebnisse der LeTriWa-Studie; Berlin, 2016 – 2020 – Teil 2 (Ergebnisse und Diskussion)

15. Infektionsquellensuche bei ambulant erworbenen Fällen von Legionärskrankheit – Ergebnisse der LeTriWa-Studie; Berlin, 2016–2020

16. Infektionsquellensuche bei ambulant erworbenen Fällen von Legionärskrankheit

18. Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (Clinical Research in Cardiology, (2022), 111, 5, (560-573), 10.1007/s00392-022-01996-2)

20. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study

22. Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX

24. Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study

27. Source attribution of community-acquired cases of Legionnaires’ disease–results from the German LeTriWa study

28. Results of intensified source finding efforts among community-acquired cases of Legionnaires disease - First results of the German LeTriWa study; Berlin, 2016-2019

29. Appropriate Shocks and Mortality in Patients With Versus Without Diabetes With Prophylactic Implantable Cardioverter Defibrillators

31. Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial

34. Source attribution of community-acquired cases of Legionnaires’ disease–results from the German LeTriWa study; Berlin, 2016–2019

36. Herzinfarktsterblichkeit innerhalb und außerhalb der Kliniken in Berlin

38. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

39. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial

40. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

42. Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial

45. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

46. Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study

47. Effect of renal insufficiency and diabetes mellitus on in-hospital mortality after acute coronary syndromes treated with primary PCI. Results from the ALKK PCI Registry

48. Transmission and loss of ECG snapshots: Remote monitoring in implantable cardiac monitors

49. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

50. Implantable Holter

Catalog

Books, media, physical & digital resources